Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Takeda, Koichi Noguchi, W. Shi, Takashi Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, S. Akira (1997)
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.Proceedings of the National Academy of Sciences of the United States of America, 94 8
D. Evans, Dewardener He, Curtis, J. Storey, P. Jennings (1965)
NEW PATHOLOGICAL INSTITUTE AT THE LONDON.Lancet, 1 7393
A. Freeman, D. Kleiner, Hari Nadiminti, Joie Davis, M. Quezado, V. Anderson, J. Puck, S. Holland (2007)
Causes of death in hyper-IgE syndrome.The Journal of allergy and clinical immunology, 119 5
Seung Park, Kaoru Saijo, Takamune Takahashi, Masataka Osawa, Hisashi Areas, Nakami Hirayama, Keiko Miyake, Hiromitsu Nakauchi, Takuji Shirasawa, Takashi Saito (1995)
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.Immunity, 3 6
P. Macchi, A. Villa, S. Giliani, M. Sacco, A. Frattini, F. Porta, A. Ugazio, J. Johnston, F. Candotti, John O'Sheai, P. Vezzoni, L. Notarangelo (1995)
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)Nature, 377
Y. Minegishi, H. Karasuyama (2007)
Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiencyCurrent Opinion in Allergy and Clinical Immunology, 7
E. Parganas, Demin Wang, D. Stravopodis, D. Topham, J. Marine, S. Teglund, E. Vanin, S. Bodner, O. Colamonici, J. Deursen, G. Grosveld, J. Ihle (1998)
Jak2 Is Essential for Signaling through a Variety of Cytokine ReceptorsCell, 93
S. Dupuis, C. Dargemont, C. Fieschi, N. Thomassin, S. Rosenzweig, Jeff Harris, S. Holland, R. Schreiber, J. Casanova (2001)
Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 MutationScience, 293
N. Stahl, T. Boulton, T. Farruggella, N. Ip, S. Davis, B. Witthuhn, F. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, J. Ihle, G. Yancopoulos (1994)
Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.Science, 263 5143
Koichi Nakajima, Yojiro Yamanaka, K. Nakae, H. Kojima, M. Ichiba, Nobuo Kiuchi, Teruichirou Kitaoka, Toshiyuki Fukada, Masahiko Hibi, Toshio, '. Hirano (1996)
A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells.The EMBO Journal, 15
S. Holland, F. DeLeo, H. Elloumi, A. Hsu, G. Uzel, Nina Brodsky, A. Freeman, A. Demidowich, Joie Davis, M. Turner, V. Anderson, D. Darnell, P. Welch, D. Kuhns, D. Frucht, H. Malech, J. Gallin, Scott Kobayashi, Adeline Whitney, Jovanka Voyich, J. Musser, C. Woellner, A. Schäffer, J. Puck, B. Grimbacher (2007)
STAT3 mutations in the hyper-IgE syndrome.The New England journal of medicine, 357 16
M. Conley, J. Rohrer, L. Rapalus, E. Boylin, Y. Minegishi (2000)
Defects in early B‐cell development: comparing the consequences of abnormalities in pre‐BCR signaling in the human and the mouseImmunological Reviews, 178
Z. Zhong, Zilong Wen, J. Darnell (1994)
Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.Science, 264 5155
R.H. Buckley (1972)
59Pediatrics, 49
U. Wegenka, J. Buschmann, C. Lütticken, P. Heinrich, F. Horn (1993)
Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational levelMolecular and Cellular Biology, 13
J. Ihle (1995)
Cytokine receptor signallingNature, 377
R. Buckley, B. Wray, E. Belmaker (1972)
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection.Pediatrics, 49 1
J. Chehimi, M. Elder, J. Greene, L. Noroski, E. Stiehm, J. Winkelstein, K. Sullivan (2001)
Cytokine and chemokine dysregulation in hyper-IgE syndrome.Clinical immunology, 100 1
Wellington Borges, N. Augustine, Harry Hill (2000)
Defective interleukin-12/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome.The Journal of pediatrics, 136 2
B. Grimbacher, S. Holland, J. Puck (2005)
Hyper‐IgE syndromesImmunological Reviews, 203
P. Wood, C. Fieschi, C. Picard, T. Ottenhoff, J. Casanova, D. Kumararatne (2005)
Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in childrenEuropean Journal of Pediatrics, 164
B. Grimbacher, A. Schäffer, S. Holland, Joie Davis, J. Gallin, H. Malech, T. Atkinson, B. Belohradsky, R. Buckley, F. Cossu, T. Español, B. Garty, N. Matamoros, L. Myers, R. Nelson, H. Ochs, E. Renner, N. Wellinghausen, J. Puck (1999)
Genetic linkage of hyper-IgE syndrome to chromosome 4.American journal of human genetics, 65 3
J. Casanova, L. Abel (2002)
Genetic dissection of immunity to mycobacteria: the human model.Annual review of immunology, 20
S. Aujla, Yvonne Chan, M. Zheng, M. Fei, D. Askew, D. Pociask, T. Reinhart, F. McAllister, Jennifer Edeal, K. Gaus, S. Husain, J. Kreindler, P. Dubin, J. Pilewski, M. Myerburg, Carol Mason, Y. Iwakura, J. Kolls (2008)
IL-22 mediates mucosal host defense against Gram-negative bacterial pneumoniaNature Medicine, 14
M. Kasprzycka, M. Marzec, Xiaobin Liu, Qian Zhang, M. Wasik (2006)
Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3.Proceedings of the National Academy of Sciences of the United States of America, 103 26
P. Macchi (1995)
65Nature, 377
Yan Zheng, P. Valdez, D. Danilenko, Yan Hu, S. Sa, Qian Gong, Alexander Abbas, Z. Modrušan, N. Ghilardi, F. Sauvage, W. Ouyang (2008)
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogensNature Medicine, 14
Y. Minegishi, M. Saito, T. Morio, Ken Watanabe, K. Agematsu, S. Tsuchiya, H. Takada, T. Hara, N. Kawamura, T. Ariga, H. Kaneko, N. Kondo, I. Tsuge, A. Yachie, Y. Sakiyama, T. Iwata, F. Bessho, T. Ohishi, K. Joh, K. Imai, K. Kogawa, M. Shinohara, M. Fujieda, H. Wakiguchi, S. Pašić, M. Abinun, H. Ochs, E. Renner, A. Jansson, B. Belohradsky, A. Metin, N. Shimizu, S. Mizutani, T. Miyawaki, S. Nonoyama, H. Karasuyama (2006)
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.Immunity, 25 5
K. Shimoda, Kouji Kato, K. Aoki, T. Matsuda, A. Miyamoto, M. Shibamori, M. Yamashita, A. Numata, K. Takase, S. Kobayashi, Shouichirou Shibata, Y. Asano, H. Gondo, Sekiguchi Kazuo, Kei-ichi Nakayama, T. Nakayama, T. Okamura, S. Okamura, Y. Niho, K. Nakayama (2000)
Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.Immunity, 13 4
M. Minami, M. Inoue, S. Wei, K. Takeda, M. Matsumoto, T. Kishimoto, S. Akira (1996)
STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.Proceedings of the National Academy of Sciences of the United States of America, 93 9
L. Williams, Laura Bradley, Alexandra Smith, B. Foxwell (2004)
Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human MacrophagesThe Journal of Immunology, 172
S. Rodig, M. Meraz, J. White, P. Lampe, J. Riley, C. Arthur, K. King, K. Sheehan, L. Yin, D. Pennica, Eugene Johnson, R. Schreiber (1998)
Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic ResponsesCell, 93
C. Lütticken, U. Wegenka, Ju-lin Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A. Harpur, A. Wilks, K. Yasukawa, T. Taga (1994)
Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130.Science, 263 5143
H. Neubauer, A. Cumano, Mathias Müller, Hong Wu, U. Huffstadt, K. Pfeffer (1998)
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesisCell, 93
E. Renner, T. Torgerson, Stacey Rylaarsdam, Stephanie Anover-Sombke, Karin Golob, Taylor LaFlam, Qili Zhu, H. Ochs (2007)
STAT3 mutation in the original patient with Job's syndrome.The New England journal of medicine, 357 16
S. Akira, Y. Nishio, M. Inoue, Xue-jie Wang, Shi We, T. Matsusaka, Kanji Yoshida, T. Sudo, M. Naruto, T. Kishimoto (1994)
Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathwayCell, 77
Kathleen Liu, S. Gaffen, Mark Goldsmith (1998)
JAK/STAT signaling by cytokine receptors.Current opinion in immunology, 10 3
Marina Karaghiosoff, H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, K. Pfeffer, M. Müller, Mathias Müller (2000)
Partial impairment of cytokine responses in Tyk2-deficient mice.Immunity, 13 4
J. O’Shea, M. Gadina, R. Schreiber (2002)
Cytokine Signaling in 2002 New Surprises in the Jak/Stat PathwayCell, 109
E. Renner, J. Puck, S. Holland, M. Schmitt, M. Weiss, M. Frosch, M. Bergmann, Joie Davis, B. Belohradsky, B. Grimbacher (2004)
Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.The Journal of pediatrics, 144 1
S. Itoh, N. Udagawa, N. Takahashi, F. Yoshitake, H. Narita, S. Ebisu, K. Ishihara (2006)
A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.Bone, 39 3
D. Toy, D. Kugler, M. Wolfson, T. Bos, Jesse Gurgel, J. Derry, J. Tocker, J. Peschon (2006)
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor ComplexThe Journal of Immunology, 177
J. Milner, J. Brenchley, A. Laurence, A. Freeman, Brenna Hill, K. Elias, Y. Kanno, C. Spalding, H. Elloumi, Michelle Paulson, Joie Davis, A. Hsu, A. Asher, J. O’Shea, S. Holland, W. Paul, D. Douek (2008)
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature, 452
I. Firmbach-Kraft (1990)
1329Oncogene, 5
T. Nosaka, J. Deursen, R. Tripp, W. Thierfelder, B. Witthuhn, A. McMickle, P. Doherty, G. Grosveld, J. Ihle (1995)
Defective Lymphoid Development in Mice Lacking Jak3Science, 270
C. Bacon, D. McVicar, J. Ortaldo, R. Rees, J. O’Shea, James Johnston (1995)
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL- 12The Journal of Experimental Medicine, 181
K. Wolk, S. Kunz, Ellen Witte, M. Friedrich, K. Asadullah, R. Sabat (2004)
IL-22 increases the innate immunity of tissues.Immunity, 21 2
Y. Minegishi, J. Rohrer, E. Coustan-Smith, H. Lederman, R. Pappu, D. Campana, D. Campana, A. Chan, M. Conley (1999)
An essential role for BLNK in human B cell development.Science, 286 5446
B. Grimbacher, S. Holland, J. Gallin, F. Greenberg, S. Hill, H. Malech, Judith Miller, A. O’Connell, J. Puck (1999)
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.The New England journal of medicine, 340 9
Katharina Kreymborg, Ruth Etzensperger, L. Dumoutier, Stefan Haak, A. Rebollo, T. Buch, F. Heppner, J. Renauld, B. Becher (2007)
IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1The Journal of Immunology, 179
Mathias Müller, J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. Harpur, G. Barbieri, B. Witthuhn, C. Schindler, S. Pellegrini, A. Wilks, J. Ihle, G. Stark, lan Kerr (1993)
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transductionNature, 366
Y. Minegishi, M. Saito, S. Tsuchiya, I. Tsuge, H. Takada, T. Hara, N. Kawamura, T. Ariga, S. Pašić, O. Stojković, A. Metin, H. Karasuyama (2007)
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndromeNature, 448
G. Prete, A. Tiri, E. Maggi, M. Carli, D. Macchia, P. Parronchi, M. Rossi, M. Pietrogrande, M. Ricci, S. Romagnani (1989)
Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome.The Journal of clinical investigation, 84 6
Y. Minegishi, E. Coustan-Smith, Yui-Hsi Wang, M. Cooper, D. Campana, M. Conley (1998)
Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and AgammaglobulinemiaThe Journal of Experimental Medicine, 187
I. Firmbach-Kraft, M. Byers, Shows Tb, R. Dalla-Favera, John Krolewski (1990)
tyk2, prototype of a novel class of non-receptor tyrosine kinase genes.Oncogene, 5 9
Xuexian Yang, Athanasia Panopoulos, R. Nurieva, S. Chang, Demin Wang, S. Watowich, C. Dong (2007)
STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells*Journal of Biological Chemistry, 282
L. Velazquez, M. Fellous, G. Stark, S. Pellegrini (1992)
A protein tyrosine kinase in the interferon α β signaling pathwayCell, 70
U.M. Wegenka (1993)
276Mol Cell Biol, 13
S. Akira (2000)
Roles of STAT3 defined by tissue-specific gene targetingOncogene, 19
S. Russell, N. Tayebi, H. Nakajima, M. Riedy, Joseph Roberts, M. Aman, T. Migone, M. Noguchi, M. Markert, R. Buckley, J. O’Shea, W. Leonard (1995)
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid DevelopmentScience, 270
Starkey Davis, J. Schaller, R. Wedgwood, M. Harvard (1966)
Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.The Lancet, 287
Hyper-IgE syndrome (HIES) is a complex primary immunodeficiency characterized by high serum IgE, chronic eczematoid dermatitis, and recurrent extracellular bacterial infections. Two types of HIES have been reported: type 1 and type 2. Type 1 HIES displays abnormalities in multiple systems, including the skeletal, dental, and immune systems, whereas type 2 shows abnormalities confined to the immune system. We recently identified hypomorphic mutations in the signal transducer and activator of transcription 3 (STAT3) gene in type 1 HIES and a null mutation in the tyrosine kinase 2 (Tyk2) gene, accompanied by susceptibility to intracellular bacteria in type 2 HIES. Analyses of cytokine responses in both types of HIES revealed that severe defects in the signal transduction for multiple cytokines, including interleukin-6 and interleukin-23, are leading to impaired T-helper type 17 function. These findings suggest that HIES is caused by the defects in multiple cytokine signals and that the susceptibility to various infections in HIES is associated with the T-helper type 17 defect.
Current Allergy and Asthma Reports – Springer Journals
Published: Sep 1, 2008
Keywords: Atopic Dermatitis; Autosomal Recessive; Autosomal Dominant; Hypomorphic Mutation; Dental Abnormality
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.